We require doctors and pharmacists to provide their feedback on a reconstitution drug mixture device which is currently under evaluation. This involves attending an in-person study session where you will be asked to review and provide your feedback on the product.  

What is the eligibility criteria?

Doctors and Pharmacists who hold a medical degree with at least one years experience in their profession. All participants must be over the age of 21 years old, be a UK resident and have not participated in a related research study in the last 6 months. Participants will be required to pass through the a screening questionnaire to determine eligibility before they can be accepted into the study. ‍

What can I expect?

Doctors are required to attend a 90 minute study session and Pharmacists a 45 minute session. The research will be conducted by a team of researchers who are specialists in conducting this type of research for medical devices. Participants must be confident in providing their opinion on the device, packaging and instructions for use so a good level of English is required.

Will I receive compensation?

There is a fare financial compensation fee available to participants. The incentive fees are kept fare and reasonable to avoid undue bias. Doctors will receive a £200 incentive fee and Pharmacists £150, to cover time, travel and opinions.
Payment of compensation fees are directly by bank transfer and include any time and travel costs incurred attending the study. This is a research exercise and there is absolutely no selling involved.

When and where is it taking place?

The study is taking place between 15th - 26th January.
- Doctors sessions run from 18th - 23rd January
- Pharmacist sessions run from 23rd - 25th January
The venue is at a research facility in Marylebone W1 and is easily accessed by public transport and rail links.

How do I apply?

To be part of this study please register using the relevant button below. You will then be sent a short study screening form. All submissions are completely confidential.
Thank you for your interest.